Research

facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604July 9, 2014

Penn to Lead $22.5 Million Project on Restoring Memory Loss

blurb: 
Penn scientists and physicians will conduct fundamental research on the brain with the aim of developing "neuroprosthetic" devices for treating memory loss due to disease or traumatic injury.

A team of scientists and physicians at the University of Pennsylvania will lead a four-year effort worth as much as $22.5 million to develop next-generation technologies to restore memory function in people who suffer from memory loss due to disease or traumatic injury.

facebook twitter google print email
Media Contact:Holly Auer | holly.auer@uphs.upenn.edu | 215-349-5659July 7, 2014

Penn's Personalized Cellular Therapy for Leukemia Receives FDA's Breakthrough Therapy Designation

A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration’s Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL).

facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604July 6, 2014

Penn Researchers: Consider the ‘Anticrystal’

blurb: 
Physicists at the University of Pennsylvania and the University of Chicago have evidence that a new concept should undergird our understanding of most materials.

For the last century, the concept of crystals has been a mainstay of solid-state physics. Crystals are paragons of order; crystalline materials are defined by the repeating patterns their constituent atoms and molecules make.

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658June 30, 2014

Penn Immunologist to Co-direct $12 Million Grant to Study Hepatitis

John Wherry, PhD, an associate professor of Microbiology in the Perelman School of Medicine at the University of Pennsylvania, and colleagues from Massachusetts General Hospital (MGH) are co-directing a $12 million grant to study immune responses in people who have been effectively cured of hepatitis C viral infection with new, high-potency antiviral drugs.

facebook twitter google print email
Media Contact:Katie Delach | Katie.Delach@uphs.upenn.edu | 215-349-5964July 3, 2014

Penn Study: Computer-Automated, Time-Lapse Embryo Photography May Increase Success of In-Vitro Fertilization

Using computer-automated, time-lapse photography of embryos in the laboratory during in-vitro fertilization may improve embryo selection, potentially increasing the chances of pregnancy among women undergoing the procedure, according to new research from the Perelman School of Medicine at the University of Pennsylvania and five other fertility centers.

facebook twitter google print email
Media Contact:Steve Graff | stephen.graff@uphs.upenn.edu | 215-349-5653July 2, 2014

Major Gaps in Hepatitis C Care Identified As New Drugs and Screening Efforts Emerge, Penn Study Finds

A new meta-analysis published online in PLOS ONE by infectious disease and epidemiology specialists from the Perelman School of Medicine at the University of Pennsylvania highlights significant gaps in hepatitis C care that will prove useful as the U.S. health care system continues to see an influx of patients with the disease because of improved screening efforts and new, promising drugs.

Lead in Kids’ Blood Linked to Behavioral Problems

July 2, 2014

Jianghong Liu of the School of Nursing writes, “Young children are particularly vulnerable to the toxic effects of lead, because lead can affect children’s developing nerves and brains.”

Article Source: Delhi Daily News (India)
facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604July 7, 2014

UTRC Gift Establishes Robotics Fellowship at University of Pennsylvania

United Technologies Research Center, the research and innovation arm of United Technologies Corp., has given $250,000 gift to the University of Pennsylvania School of Engineering and Applied Science to establish a fellowship in robotics.

facebook twitter google print email
Media Contact:Steve Graff | stephen.graff@uphs.upenn.edu | 215-349-5653June 30, 2014

HIV-infected People with Early-Stage Cancers are up to Four Times More Likely to Go Untreated for Cancer, Penn Study Finds

HIV-infected people diagnosed with cancer are two to four times more likely to go untreated for their cancer compared to uninfected cancer patients, according to a new, large retrospective study from researchers in Penn Medicine’s Abramson Cancer Center and the National Cancer Institute (NCI) published online ahead of print in the Journal of Clinical Oncology.

If You’re HIV-Positive, You’re Less Likely to Get Cancer Treatment

June 30, 2014

Gita Suneja of the Perelman School of Medicine discusses a study of HIV-infected patients who are less likely to receive cancer treatment.

Article Source: Newsweek